Entyvio safe, effective for refractory pouchitis

Entyvio is safe and effective for the treatment of Crohn’s disease of the pouch and chronic pouchitis, according to data published in Inflammatory Bowel Diseases.
Parakkal Deepak, MBBS, MS, of the division of gastroenterology at Washington University School of Medicine in St. Louis, and colleagues wrote that inflammation of the pouch after ileal pouch-anal anastomosis can have a significant impact on a patient’s life and be quite difficult to treat.
“Optimal treatment for pouchitis that is refractory or dependent to antibiotics is unknown,” they wrote. “The

Source link

Related posts

Statins and Postcolonoscopy Colorectal Cancer Risk


FDA: Higher doses of Xeljanz increase blood clot, death risk in UC


Sugar-sweetened beverages — another study recommends replacement


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy